The Network Of Applied Pharmacognosy
NAP is a 501(c)(3) nonprofit founded in 2023 that runs community-led longitudinal real-world evidence studies on cannabis and natural products, partnering with MoreBetter for data infrastructure and industry sponsors for study funding, and publishing findings via blog, podcast, and conferences.
- Company typePrivate
- Founded2023
- HeadquartersSalem, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What The Network Of Applied Pharmacognosy does
The Network of Applied Pharmacognosy (NAP) is a US-based 501(c)(3) nonprofit research organization founded in 2023 by PhDs Riley Kirk and Miyabe Shields. It runs community-led, longitudinal real-world evidence studies on cannabis and adjacent natural products (including Kratom and Kava), partnering with MoreBetter (Releaf App) for mobile data capture and with industry sponsors such as DaySavers, Custom Cones USA, the Cannabis Research Coalition (Clemson University / The Hemp Mine), Controlled Chemistry, Operator Academy, and Leafwell to scope and resource specific studies. NAP's research portfolio spans dosing (including a flagship n=2,857 longitudinal study and a 4,591-participant concentrate dataset), neurodivergent and autistic cannabis use (2.2M+ datapoints), hemp-derived cannabinoid beverages (18,000+ reports), intimacy, and the Science of Smokeability pre-roll study, with findings published through a blog, whitepapers, the Bioactive Podcast, and conference panels at NECANN, MJUnpacked, and Emerald Cup.
The organization funds operations through tax-deductible donations (collected via the Zeffy platform), in-kind product donations from concentrate and pre-roll manufacturers, and collaborative research partnerships that supply funding and shared resources. It also operates adjacent programs — the Higher Potential Scholarship Coalition with DaySavers (200+ awards, $25K+ in 2025) and the Weird Brains science advocacy tour with Future4200 — that extend reach into both consumer and industry segments. NAP is governed by its co-founders and a Scientific Advisory Board spanning cannabis cultivation, public health, endocrinology, and medical cannabis education, and operates as a distributed organization with no publicly disclosed office.
The Network Of Applied Pharmacognosy firmographics
Firmographics- Name
- The Network Of Applied Pharmacognosy
- Legal name
- Network of Applied Pharmacognosy
- Website
- https://appliedpharmacognosy.org
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- NAP is a 501(c)(3) nonprofit founded in 2023 that runs community-led longitudinal real-world evidence studies on cannabis and natural products, partnering with MoreBetter for data infrastructure and industry sponsors for study funding, and publishing findings via blog, podcast, and conferences.
- Ownership category
- akta.pro rank
The Network Of Applied Pharmacognosy industry classification
Industry- Product category
- Cannabis and Natural Products Research
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)
Keywords
Where The Network Of Applied Pharmacognosy is headquartered
LocationHeadquarters
- HQ city
- Salem
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Network Of Applied Pharmacognosy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Donations and Charitable Contributions: As a 501(c)(3) nonprofit organization (EIN: 41-3946895), NAP relies on tax-deductible donations from the community to fund independent research. The organization conducts crowdfunding campaigns such as 'Stoner Science Breaks the Stigma' to raise funds for research initiatives.
- Collaborative Research Partnerships: NAP collaborates with aligned industry and academic partners on research projects, which may include funding support, in-kind donations of products, or shared research resources.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
The Network Of Applied Pharmacognosy product offering
Product offeringCore offering
The Network of Applied Pharmacognosy (NAP) is a 501(c)(3) nonprofit that conducts community-led, longitudinal observational research on cannabis and natural products by collecting real-world evidence directly from consumers and patients through mobile surveys and the Releaf App platform (via MoreBetter). The organization also produces public education resources, hosts the Bioactive Podcast, runs the Higher Potential Scholarship program with DaySavers, operates the Weird Brains science advocacy tour with Future4200, and partners with Leafwell for medical cannabis card access advocacy.
Product overview
The Network of Applied Pharmacognosy (NAP) is a 501(c)(3) nonprofit research organization that operates as a community-centered research and education platform rather than a traditional product company. Its core offering is a real-world evidence research platform that collects longitudinal cannabis and natural product consumption data directly from consumers via surveys and the Releaf App, producing large-scale behavioral datasets. Supporting services include public education resources (blog, whitepapers, lectures), the Bioactive Podcast, a Scientific Advisory Board, the Weird Brains Science Advocacy Tour, and the Higher Potential Scholarship program. NAP also partners with Leafwell for medical cannabis card access advocacy. Together, these programs bridge academic research, the cannabis industry, and lived-experience-led science to empower community-led, inclusive cannabis research.
Differentiator
Problem solved
Functional benefit
Products and services
- Real-World Evidence Research Platform A citizen-science research platform that collects longitudinal, real-world cannabis and natural product consumption data directly from consumers and patients via mobile surveys and the Releaf App, generating high-resolution behavioral datasets for cannabis and natural products research. The platform serves researchers, industry partners, and academic collaborators seeking real-world evidence on actual consumer use patterns.
- Bioactive Podcast A bi-weekly podcast hosted by Dr. Riley Kirk covering the chemistry and pharmacology of natural products including cannabis, psychedelics, pharmaceuticals, and other bioactive substances. Special NAPTIME episodes feature NAP research updates. It is targeted at cannabis consumers, researchers, and industry professionals seeking accessible natural product science education.
- Higher Potential Scholarship
Companies that use The Network Of Applied Pharmacognosy
Customer profileSegments3 records
Ideal customer profiles3 records
The Network Of Applied Pharmacognosy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
The Network Of Applied Pharmacognosy partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Operator AcademyminorNAP partnered with Operator Academy to collect real-world dab-dosing data at NECANN 2026. Operator Academy, a cannabis workforce training and operations consultancy, hosted the 'Morning Melt' event where attendees participated in NAP's concentrate dosing study.
- Jar Cannabis Co, Cape Cod Grow Lab, Harbor House Collective, Lunar XtractsminorConcentrate manufacturers that donated rosin and butane hash oil (BHO) products for NAP's 'Normal Dab Size' research study at NECANN 2026.
- MoreBetter (Releaf App)coreNAP's primary research collaborator on longitudinal observational studies. MoreBetter, creators of the Releaf App, provides data software infrastructure for NAP's community-based cannabis research. Together they conduct studies on cannabis use patterns, including the largest longitudinal dataset of the cannabis community with thousands of participants tracking daily use, cannabinoid preferences, and health outcomes.
- DaySavers / Custom Cones USAcoreNAP partners with DaySavers on the 'Science of Smokeability' (SOS) study, examining how cultivation and processing affect cannabis smoke quality. DaySavers provides funding and compensates 200 participants for qualitative surveys comparing pre-rolls. Custom Cones USA also sponsors experiments on infused pre-rolls analyzing burn temperature and cannabinoid delivery.
- Cannabis Research CoalitioncoreNAP collaborates with the Cannabis Research Coalition (CRC), a partnership between Clemson University and The Hemp Mine focused on cannabis cultivation and postharvest challenges. CRC brings expertise in cultivation science to the Science of Smokeability study.
- LeafwellminorNAP partnered with Leafwell, the world's largest medical cannabis card provider, to educate the public about medical cannabis cards and help individuals feel more confident about obtaining cards. NAP records interviews with Leafwell's Chief Medical Officer Dr. June Chin and provides referral codes for discounts.
- The Hemp MinecoreThe Hemp Mine, led by Scientific Advisory Board member Dr. Allison Justice, is a 20-acre hemp farm, breeding company, and product manufacturer. The company co-founded the Cannabis Research Coalition with NAP and provides expertise in cultivation science.
- University of Maryland Eastern ShoreminorNAP's Higher Potential Scholarship supports PhD student Freweyni Abrha at UMES in researching hemp's molecular defense mechanisms and the impact of insect herbivory on cannabinoid production.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
The Network Of Applied Pharmacognosy competitors and assessment
Company assessmentDirect peers
- Multidisciplinary Association for Psychedelic Studies (MAPS): 501(c)(3) nonprofit that funds and conducts rigorous scientific research on psychedelics and marijuana, advocating for regulatory approval and public access. Operates a structurally similar nonprofit research model focused on stigmatized natural products, making it a strong mission and operating-model peer for NAP.
- Drug Science: Independent, science-led nonprofit that provides evidence-based information on drug harms, policy, and therapeutics, including cannabis and psychedelics. Shares NAP's positioning as an independent research/education body outside of commercial industry influence and serves as a comparable model for translating evidence into public communication.
- MoreBetter (Releaf App): Creator of the Releaf App, a consumer-facing cannabis use tracking platform and the primary data infrastructure partner for NAP's longitudinal studies. Both organizations collect real-world cannabis consumption data from consumer/patient users via mobile app, making MoreBetter the closest functional peer in the cannabis RWE category.
- Strainprint: Canadian cannabis patient-tracking and outcomes platform that collects real-world strain-, dose-, and symptom-level data from patients to generate RWE for clinicians and licensed producers. Directly comparable to NAP's longitudinal observational methodology, with overlapping scientific advisory networks and use of patient-generated data.
- Cannabis Research Coalition: Research partnership between Clemson University and The Hemp Mine focused on cannabis cultivation, postharvest, and product-quality science; an existing NAP partner on the Science of Smokeability study. Closely comparable research agenda and stakeholder mix to NAP's cultivation and product-focused studies.
Emerging players
- Leafwell: Largest medical cannabis card provider in the US, offering telehealth certifications and patient-education resources. Listed as a NAP partner for medical-cannabis-card referrals; comparable in audience (medical cannabis patients) and content/education mission but distinct in monetizing certifications rather than research.
Others
- NORML: Long-standing nonprofit cannabis policy reform organization that combines advocacy with public education. Functions as a comparable nonprofit operating model and cannabis-community audience builder, though NORML's focus is policy advocacy rather than scientific research.
Broad incumbents
- Tilray Brands: Large global cannabis and pharmaceutical company with operations across cultivation, distribution, branded products, and pharma-grade cannabinoid research. Represents the broad incumbent counterpart to NAP's niche cannabis research activities and a potential partner for sponsored RWE studies at scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
The Network Of Applied Pharmacognosy social profiles
Digital presenceThe Network Of Applied Pharmacognosy compliance and trust
Trust signalCompliance1 record
The Network Of Applied Pharmacognosy financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Network Of Applied Pharmacognosy leadership team
Management profileNumber of profiles
Profiles2 records
The Network Of Applied Pharmacognosy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Network Of Applied Pharmacognosy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Network Of Applied Pharmacognosy
What does The Network Of Applied Pharmacognosy do?
The Network of Applied Pharmacognosy (NAP) is a 501(c)(3) nonprofit that conducts community-led, longitudinal observational research on cannabis and natural products by collecting real-world evidence directly from consumers and patients through mobile surveys and the Releaf App platform (via MoreBetter). The organization also produces public education resources, hosts the Bioactive Podcast, runs the Higher Potential Scholarship program with DaySavers, operates the Weird Brains science advocacy tour with Future4200, and partners with Leafwell for medical cannabis card access advocacy.
Is The Network Of Applied Pharmacognosy a public or private company?
The Network Of Applied Pharmacognosy is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Network Of Applied Pharmacognosy founded?
The Network Of Applied Pharmacognosy was founded in 2023. It employs 1 to 10 people.
Where is The Network Of Applied Pharmacognosy based?
The Network Of Applied Pharmacognosy is headquartered in Salem, United States, in the North America region.
How does The Network Of Applied Pharmacognosy make money?
Two revenue lines are on record. Donations and Charitable Contributions are the primary driver. The others are collaborative Research Partnerships.
Who are The Network Of Applied Pharmacognosy's main competitors?
Direct peers on record are Multidisciplinary Association for Psychedelic Studies (MAPS), Drug Science, MoreBetter (Releaf App), Strainprint and Cannabis Research Coalition. Leafwell is listed as an emerging player. NORML is listed as an others. Tilray Brands is listed as a broad incumbent.
Does The Network Of Applied Pharmacognosy have an API?
No public API is recorded for The Network Of Applied Pharmacognosy.
What industry is The Network Of Applied Pharmacognosy in?
The Network Of Applied Pharmacognosy's product category is Cannabis and Natural Products Research. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 54171 and its SIC code is 8731.